Correlation Between Dogwood Therapeutics, and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Dogwood Therapeutics, and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and CERo Therapeutics.

Diversification Opportunities for Dogwood Therapeutics, and CERo Therapeutics

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Dogwood and CERo is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and CERo Therapeutics

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 13.12 times less return on investment than CERo Therapeutics. But when comparing it to its historical volatility, Dogwood Therapeutics, is 3.24 times less risky than CERo Therapeutics. It trades about 0.02 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  7.00  in CERo Therapeutics Holdings on September 2, 2024 and sell it today you would lose (5.02) from holding CERo Therapeutics Holdings or give up 71.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy29.84%
ValuesDaily Returns

Dogwood Therapeutics,  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Dogwood Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
CERo Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dogwood Therapeutics, and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dogwood Therapeutics, and CERo Therapeutics

The main advantage of trading using opposite Dogwood Therapeutics, and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Dogwood Therapeutics, and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world